Adam O’DEll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adam O’DEll has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bodour Salhia
Department of Translational Genomics, Keck School of Medicine, University of Southern California and Norris Comprehensive Cancer Center, Los Angeles, USA
40 shared publications - David D. Tran
University of Southern California 3 Division of Neuro-Oncology, Keck School of Medicine, Norris Comprehensive Cancer Center Los Angeles, California
40 shared publications - Dongjiang Chen
Division of Neuro-Oncology, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
40 shared publications - Harshit Manektalia
Division of Neuro-Oncology, Brain Tumor Center, Keck School of Medicine of University of Southern California, Los Angeles, California
40 shared publications - Son B. Le
University of Southern California 3 Division of Neuro-Oncology, Keck School of Medicine, Norris Comprehensive Cancer Center Los Angeles, California
40 shared publications - Tarun E. Hutchinson
Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida, United States of America
40 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S8 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 promotes self-renewal in TTFields-resistant GBM cells. (Supporting Main Figure 4)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S8 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 promotes self-renewal in TTFields-resistant GBM cells. (Supporting Main Figure 4)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S9 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3i re-sensitizes freshly isolated TTFields-resistant GSC to the cytotoxic effects of TTFields as measured by the extreme limiting dilution assay. (Supporting Main Figure 5)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S9 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3i re-sensitizes freshly isolated TTFields-resistant GSC to the cytotoxic effects of TTFields as measured by the extreme limiting dilution assay. (Supporting Main Figure 5)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S12 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 is co-localized with ZNF488 in the nucleus of TTFields-resistant GBM cells. (Supporting Main Figure 7)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S12 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 is co-localized with ZNF488 in the nucleus of TTFields-resistant GBM cells. (Supporting Main Figure 7)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S4 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
The top 10 nSCORE ranked MRs in the same 7D and 28–35D TTFields-treated conditions of the 3 GBM lines, showing that ZNF488 is the highest ranked master regulator that is upregulated in the stemness hub after EP3, suggesting that it may be a co-master regulator with EP3 in controlling the stem cell fraction of GBM. (Supporting Main Figure 6)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S4 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
The top 10 nSCORE ranked MRs in the same 7D and 28–35D TTFields-treated conditions of the 3 GBM lines, showing that ZNF488 is the highest ranked master regulator that is upregulated in the stemness hub after EP3, suggesting that it may be a co-master regulator with EP3 in controlling the stem cell fraction of GBM. (Supporting Main Figure 6)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S1 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Bulk RNA-seq output of the 3 established GBM lines treated with TTFields for 0 (NT), 7 (7D), and 28/35 (28/35D) days. (Supporting Main Figures 1, 2, and 7)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S1 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Bulk RNA-seq output of the 3 established GBM lines treated with TTFields for 0 (NT), 7 (7D), and 28/35 (28/35D) days. (Supporting Main Figures 1, 2, and 7)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S6 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Dose optimization of aspirin, L798,106, and DG041. (Supporting Main Figure 2)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S6 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Dose optimization of aspirin, L798,106, and DG041. (Supporting Main Figure 2)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S11 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 co-localizes with ZNF488 in the nucleus of TTFields-resistant GBM cells. (Supporting Main Figure 7)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S11 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 co-localizes with ZNF488 in the nucleus of TTFields-resistant GBM cells. (Supporting Main Figure 7)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S7 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 inhibition and overexpression reverses and induces TTFields resistance, respectively, in GBM cells. (Supporting Main Figure 2)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S7 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
EP3 inhibition and overexpression reverses and induces TTFields resistance, respectively, in GBM cells. (Supporting Main Figure 2)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S10 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
ZNF488 is required to maintain TTFields resistance in GSC and GBM cells. (Supporting Main Figure 6)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S10 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
ZNF488 is required to maintain TTFields resistance in GSC and GBM cells. (Supporting Main Figure 6)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Temporal evolution of complete nSCORE rankings of all master regulators during continuous TTFields treatment in the 3 established GBM cell lines. (Supporting Main Figure 1D-E)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
Temporal evolution of complete nSCORE rankings of all master regulators during continuous TTFields treatment in the 3 established GBM cell lines. (Supporting Main Figure 1D-E)